PuSH - Publication Server of Helmholtz Zentrum München

35 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Jesinghaus, M.* et al.: Cellular dissociation grading based on the parameters tumor budding and cell nest size in pretherapeutic biopsy specimens allows for prognostic patient stratification in esophageal squamous cell carcinoma independent from clinical staging. Am. J. Surg. Pathol. 43, 618-627 (2019)
2.
Münch, S.* et al.: Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus. Radiat. Oncol. 14:66 (2019)
3.
Jian, Z.* et al.: Glycemic variability promotes both local invasion and metastatic colonization by pancreatic ductal adenocarcinoma. Cell. Mol. Gast. Hept. 6, 429-449 (2018)
4.
Kessel, K.A. et al.: Cancer Clinical Trials - survey evaluating patient participation and attitude in an Oncology Center. Radiother. Oncol. 127, S50-S50 (2018)
5.
Kessel, K.A. et al.: Cancer clinical trials - Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC). Clin. Transl. Radiat. Oncol. 13, 44-49 (2018)
6.
Münch, S.* et al.: Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma. A population-based evaluation of the Munich Cancer Registry. Strahlenther. Onkol. 194, 125-135 (2018)
7.
Münch, S.* et al.: Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus. Radiat. Oncol. 13:182 (2018)
8.
Kessel, K.A. et al.: mHealth in oncology: A Patient survey evaluating the acceptance of app-assisted cancer treatment. Int. J. Radiat. Oncol. Biol. Phys. 99, E402-E402 (2017)
9.
Kessel, K.A. et al.: Mobile applications in oncology - a survey on evaluating the patient acceptance in a German Oncology Center: Final analysis. Strahlenther. Onkol. 193, S23-S24 (2017)
10.
Kessel, K.A. et al.: Mobile health in oncology: A patient survey about app-assisted cancer care. JMIR 5:e81 (2017)
11.
Muench, S.* et al.: Comparison of perioperative chemotherapy and neoadjuvant chemoradiation in patients with adenocarcinoma of the gastro-esophageal junction: A population-based evaluation of the Munich Cancer Registry. Strahlenther. Onkol. 193, S33-S34 (2017)
12.
Münch, S.* et al.: Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus. Radiat. Oncol. 12:182 (2017)
13.
Kessel, K.A. et al.: Use of Complementary and Alternative Medicine (CAM) as part of the oncological treatment: Survey about patients' attitude towards CAM in a university-based oncology center in Germany. PLoS ONE 11:e0165801 (2016)
14.
Kong, B.* et al.: A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling. Gut 65, 647-657 (2016)
15.
Kong, B.* et al.: Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy. Gut 67, 146-156 (2016)
16.
Kong, B.* et al.: Oncogenic Kras promotes early pancreatic carcinogenesis by perpetuating elements of natural inflammatory response. Pancreatol. 16, S. 11 (2016)
17.
Sunami, Y.* et al.: Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in HBV surface antigen-driven HCC by controlling the UPR. Hepatology 63, 1592-1607 (2016)
18.
Sunami, Y.* et al.: Canonical NF-kappa B signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response. Hepatology 63, 1, 233A-233A (2016)
19.
Sprinzl, M.F. et al.: Sorafenib perpetuates cellular anti-cancer effector functions by modulating the cross talk between macrophages and natural killer cells. Hepatology 57, 2358-2368 (2013)
20.
Becker, K.* et al.: Proposal for a multifactorial prognostic score that accurately classifies 3 groups of gastric carcinoma patients with different outcomes after neoadjuvant chemotherapy and surgery. Ann. Surg. 256, 1002-1007 (2012)